SABRA CONDRA: Open Payments
NPI 1316506967 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 36 payments from 11 companies in 2025. Trend: 2023 $2,024 · 2024 $1,625 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $387 |
| Otsuka America Pharmaceutical, Inc. | 6 | $200 |
| Axsome Therapeutics, Inc. | 3 | $142 |
| Novo Nordisk Inc | 9 | $140 |
| ABBVIE INC. | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $21 |
Products named: AIRSUPRA, REXULTI, Auvelity, BREZTRI, Rybelsus, VRAYLAR, GVOKE HYPOPEN, CAPLYTA.
Industry payments across TN — which companies pay providers there.
